Aquestive Therapeutics, Inc. - 8-K Filing
Aquestive Therapeutics issues investor presentation detailing Anaphylm regulatory timelines and pipeline development. (Items: 7.01 by reference)
Tickers: $AQST
Aquestive Therapeutics issues investor presentation detailing Anaphylm regulatory timelines and pipeline development. (Items: 7.01 by reference)
Tickers: $AQST